Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs

Cross-hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) is a relatively common, non-allergic, adverse drug event triggered by two or more chemically unrelated NSAIDs. Current evidence point to COX-1 inhibition as one of the main factors in its etiopathogenesis. Evidence also suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Macías, Yolanda, García-Menaya, Jesús M., Martí, Manuel, Cordobés, Concepción, Jurado-Escobar, Raquel, Cornejo-García, José A., Torres, María J., Blanca-López, Natalia, Canto, Gabriela, Blanca, Miguel, Laguna, José J., Bartra, Joan, Rosado, Ana, Fernández, Javier, García-Martín, Elena, Agúndez, José A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490926/
https://www.ncbi.nlm.nih.gov/pubmed/34621165
http://dx.doi.org/10.3389/fphar.2021.648262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490926/
https://www.ncbi.nlm.nih.gov/pubmed/34621165
http://dx.doi.org/10.3389/fphar.2021.648262

Ejemplares similares